Pfizer covid-19 pill nearly 90% effective against Omicron variant of Coronavirus

Pfizer Inc has said that its antiviral COVID-19 has about 90% efficacy in preventing hospitalizations and deaths in high-risk patients, and recent lab data suggests the drug retains its effectiveness against the Omicron variant of the coronavirus.